Digital Therapeutics and Wellness Market by Type (Scales, Blood Pressure Monitors, Blood Glucose Mon

Global Digital Therapeutics and Wellness Market Overview
Global Digital Therapeutics and Wellness Market was valued at USD 6.01 Billion in 2023 and is expected to reach USD 32.07 Billion by 2032, at a CAGR of 20.45%.

Digital therapeutics (DTx) is a digital health category referred by the Digital Therapeutics Alliance as products that provide evidence-based therapeutic involvement to patients that are turned by high-quality software programs to prevent, manage, or treat a medical disorder or disease. Digital therapeutics are distinct from digital medicines or “smart pills,” which combine a prescription medication with an ingestible sensor that is designed to communicate with a software application to track compliance. Development in and the increasingly dominant role of mobile technology and artificial intelligence (AI) in our everyday lives have expanded the role of digital therapeutics and wellness in healthcare. Even though historically, interest in emerging digital therapeutics was mainly confined to academia and technology companies, the potential to use digital therapeutics in conjunction with medicines to enhance health outcomes has sparked the interest of big pharma, who have started to venture into the digital therapeutics space through investments and strategic partnerships with tech companies. The rise in the tech-savvy population and the growing inclination towards software applications for yoga, exercise, and diet solutions is expected to propel the growth of the digital therapeutics and wellness market over the forecast period.